Helius Medical completes, exceeded target enrollment for stroke study

Helius Medical (HSDT) Technologies announced it has completed and far exceeded the initial target enrollment for its stroke registrational program. With 128 participants randomized to-date the program is on track to reach the maximum enrollment target of 150 participants by the end of January 2025. The stroke registrational program is intended to demonstrate the safety and effectiveness of the novel Portable Neuromodulation Stimulator for improving balance and gait deficits in stroke survivor